Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

Baxter International announced Monday that its CEO and board chair José Almeida is retiring, effective immediately – an ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading ...

Concluding a two-year journey, Baxter International Inc.’s kidney care unit finally separated from the company and started a new life as Vantive, following the closing on Jan. 31 of its $3.8 billion ...

Baxter (BAX) announced that Jose Almeida, chair, president and CEO, will retire from his executive roles with the company, effective ...

1Q25 Crop Care segment revenue grew 68% to R$293.7 million, led by strong performance from subsidiaries Union Agro (specialty ...

Pre-Market: 7:30:53 am GMT-5 Loading Chart for BAX ...